Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Apr;76(1):30–33.

Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.

J A Snook 1, R W Chapman 1, K Fleming 1, D P Jewell 1
PMCID: PMC1541734  PMID: 2786779

Abstract

We have previously described circulating autoantibodies to a portal tract antigen in patients with primary sclerosing cholangitis. In this study the antigen has been shown by double-labelling studies to be specifically located in the nuclei of tissue neutrophils. Using isolated peripheral blood neutrophils and an immunoperoxidase technique, anti-neutrophil nuclear antibody (ANNA) was found in the serum of 84% of patients with primary sclerosing cholangitis (PSC: n = 32) with a median titre of 1/1000 and a peak titre of 1/500,000. ANNA was also detected in 86% of patients with inflammatory bowel disease alone (IBD: n = 76) with a median titre of 1/10 and a peak titre of 1/10,000. In contrast, only 12% of controls had ANNA, and in none was the titre greater than 1/10. In PSC the ANNA titre correlated with the serum aspartate transaminase concentration, suggesting that it is related to disease activity. In IBD the titre of ANNA was significantly higher in patients with recently active disease. There was no significant difference between the titres seen in ulcerative colitis and Crohn's disease. ANNA was not associated with neutropaenia. The results provide further evidence of involvement of autoimmune mechanisms in inflammatory bowel disease and primary sclerosing cholangitis.

Full text

PDF
30

Images in this article

32Fig. 1
on p.32

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Briggs R. C., Glass W. F., 2nd, Montiel M. M., Hnilica L. S. Lactoferrin: nuclear localization in the human neutrophilic granulocyte? J Histochem Cytochem. 1981 Oct;29(10):1128–1136. doi: 10.1177/29.10.7028857. [DOI] [PubMed] [Google Scholar]
  2. CALABRESI P., EDWARDS E. A., SCHILLING R. F. Fluorescent antiglobulin studies in leukopenic and related disorders. J Clin Invest. 1959 Nov;38:2091–2100. doi: 10.1172/JCI103987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Calabresi P., Thayer W. R., Spiro H. M. DEMONSTRATION OF CIRCULATING ANTINUCLEAR GLOBULINS IN ULCERATIVE COLITIS. J Clin Invest. 1961 Dec;40(12):2126–2133. doi: 10.1172/JCI104438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chapman R. W., Arborgh B. A., Rhodes J. M., Summerfield J. A., Dick R., Scheuer P. J., Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980 Oct;21(10):870–877. doi: 10.1136/gut.21.10.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chapman R. W., Cottone M., Selby W. S., Shepherd H. A., Sherlock S., Jewell D. P. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut. 1986 Jan;27(1):86–91. doi: 10.1136/gut.27.1.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chapman R. W., Varghese Z., Gaul R., Patel G., Kokinon N., Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut. 1983 Jan;24(1):38–41. doi: 10.1136/gut.24.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  8. Erber W. N., Pinching A. J., Mason D. Y. Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet. 1984 May 12;1(8385):1042–1046. doi: 10.1016/s0140-6736(84)91451-x. [DOI] [PubMed] [Google Scholar]
  9. Faber V., Elling P. Leucocyte-specific anti-nuclear factors in patients with felty's syndrome, rheumatoid arthritis, systemic lupus erythematosus and other diseases. Acta Med Scand. 1966 Mar;179(3):257–267. doi: 10.1111/j.0954-6820.1966.tb05457.x. [DOI] [PubMed] [Google Scholar]
  10. Rosenberg J. N., Johnson G. D., Holborow E. J. Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis. Ann Rheum Dis. 1979 Dec;38(6):526–528. doi: 10.1136/ard.38.6.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Smalley M. J., Mackay I. R., Whittingham S. Antinuclear factors and human leucocytes: reaction with granulocytes and lymphocytes. Australas Ann Med. 1968 Feb;17(1):28–32. doi: 10.1111/imj.1968.17.1.28. [DOI] [PubMed] [Google Scholar]
  12. THAYER W. R., Jr, SPIRO H. M. Protein abnormalities in ulcerative colitis patients and their families. Gastroenterology. 1963 Apr;44:444–447. [PubMed] [Google Scholar]
  13. Whittingham S., Morstyn G., Wilson J. W., Vadas M. A. An autoantibody reactive with nuclei of polymorphonuclear neutrophils: a cell differentiation marker. Blood. 1981 Oct;58(4):768–771. [PubMed] [Google Scholar]
  14. Wiesner R. H., LaRusso N. F., Ludwig J., Dickson E. R. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology. 1985 Jan;88(1 Pt 1):108–114. doi: 10.1016/s0016-5085(85)80141-4. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES